Skip to Content
Morningstar

Prestige Consumer Healthcare Inc PBH

Morningstar Rating
Unlock
Stock XNYS Rating as of
$64.70 +0.05 (0.08%)
View Full Chart
As of Delayed Price Closed
Unlock our analysis with Morningstar Investor
Start Free Trial

Company Report

View Archive

Prestige Consumer Earnings: Supply Chain Disruptions and Tough Comparison Dragged Sales

Keonhee Kim

Narrow-moat Prestige Consumer Healthcare reported disappointing fourth-quarter earnings that were below our expectations. Total sales of $277 million were down 3.1% year over year, and adjusted diluted EPS of $1.02 was down from last year’s $1.07. Having said that, we maintain our fair value estimate of $68 per share as minor adjustments to our near-term outlook were offset by time value of money impacts. Shares were down about 6% at the time of writing from the soft outlook, and we think they now trade in a fair 3-star territory.

Read Full Report

Price vs Fair Value

View History
PBH is trading at a 832% premium.
Price
$64.70
Fair Value
$89.00
Uncertainty
Medium
1-Star Price
$24.20
5-Star Price
$21.10
Economic Moat
Ykxhms
Capital Allocation
Qtxvxzsjs

Bulls Say, Bears Say

Bulls

Prestige is well positioned to enjoy macro long-term trends, including aging population, rising awareness of self-care, and premiumization of consumer healthcare.

Bears

Emerging large players in the consumer healthcare space, including Haleon and Kenvue, have the resources to expand their portfolios and displace smaller brands that Prestige owns.

Show More
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if PBH is a good fit for your portfolio.
Get 7 Days Free

News

View All

Trading Information

Previous Close Price
$64.65
Day Range
$64.27–65.38
52-Week Range
$52.90–75.31
Bid/Ask
$57.23 / $67.72
Market Cap
$3.23 Bil
Volume/Avg
322,549 / 239,423

Key Statistics

Price/Earnings (Normalized)
15.35
Price/Sales
2.88
Dividend Yield (Trailing)
—
Dividend Yield (Forward)
—
Total Yield
0.77%

Company Profile

Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige’s key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer’s Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Small Core
Total Number of Employees
570
Website
https://www.prestigebrands.com

Competitors

Valuation

View More
Metric
PBH
HLN
PG
Price/Earnings (Normalized)
 15.3518.5225.61
Price/Book Value
 1.951.868.02
Price/Sales
 2.882.794.92
Price/Cash Flow
 11.2417.5920.40
Price/Earnings
PBH
HLN
PG

Financial Strength

Metric
PBH
HLN
PG
Quick Ratio
 1.910.630.40
Current Ratio
 3.201.040.64
Interest Coverage
 5.114.9420.66
Quick Ratio
PBH
HLN
PG

Profitability

Metric
PBH
HLN
PG
Return on Assets (Normalized)
 6.33%—13.82%
Return on Equity (Normalized)
 13.69%—35.61%
Return on Invested Capital (Normalized)
 9.33%—20.62%
Return on Assets
PBH
HLN
PG
See how this stock stacks up to its competitors with Morningstar Investor
Start Free Trial

Drug Manufacturers - Specialty & Generic Industry Comparables

Screen in Investor
Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
ZTS
Zoetis Inc Class AQhkyrxkzMcrn$79.4 Bil
MKKGY
Merck KGaA ADRDhltrprnnCfljcxx$79.0 Bil
HLN
Haleon PLC ADRYmvrjggkQqp$38.5 Bil
VTRS
Viatris IncGcbqwhzkjDmsp$13.1 Bil
RDY
Dr Reddy's Laboratories Ltd ADRHjytsltPztr$11.6 Bil
CTLT
Catalent IncRlcrpgvfjLdpsfd$10.0 Bil
CURLF
Curaleaf Holdings IncZnpxzlclJrky$4.2 Bil
PRGO
Perrigo Co PLCGggyltgmRtx$4.0 Bil
GTBIF
Green Thumb Industries IncPsyqxmlknjJbnsm$3.1 Bil

Sponsor Center